4523 on TSE, BUY.Price has hit Weekly Demand. The momentum line on the Daily chart is broken. This level is responsible for that removal.
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
0.905EUR
259.67 MEUR
4.54 BEUR
235.60 M
About EISAI CO LTD
Sector
CEO
Haruo Naito
Headquarters
Tokyo
Website
Founded
1936
ISIN
JP3160400002
FIGI
BBG000BZLWX9
Eisai Co., Ltd. engages in the development, manufacture, and sale of prescription medicines and over-the-counter products. It operates through the Pharmaceutical Products Business and Other Business segments. The Pharmaceutical Products Business segment handles prescription and generic drugs, diagnostics, and consumer healthcare business in Japan, which manages over-the-counter drugs. The Other Business segment deals with food additives and chemicals. The company was founded by Toyoji Naito in November 1936 and is headquartered in Tokyo, Japan.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on SWB exchange Eisai Co. Ltd. stocks are traded under the ticker EII.
We've gathered analysts' opinions on Eisai Co. Ltd. future price: according to them, EII price has a max estimate of 71.21 EUR and a min estimate of 33.82 EUR. Watch EII chart and read a more detailed Eisai Co. Ltd. stock forecast: see what analysts think of Eisai Co. Ltd. and suggest that you do with its stocks.
Yes, you can track Eisai Co. Ltd. financials in yearly and quarterly reports right on TradingView.
Eisai Co. Ltd. is going to release the next earnings report on Jul 31, 2024. Keep track of upcoming events with our Earnings Calendar.
EII earnings for the last quarter are 0.25 EUR per share, whereas the estimation was 0.25 EUR resulting in a −0.69% surprise. The estimated earnings for the next quarter are 0.13 EUR per share. See more details about Eisai Co. Ltd. earnings.
Eisai Co. Ltd. revenue for the last quarter amounts to 1.17 B EUR despite the estimated figure of 1.16 B EUR. In the next quarter revenue is expected to reach 1.09 B EUR.
EII net income for the last quarter is 81.49 M EUR, while the quarter before that showed 38.33 M EUR of net income which accounts for 112.63% change. Track more Eisai Co. Ltd. financial stats to get the full picture.
Eisai Co. Ltd. dividend yield was 2.57% in 2023, and payout ratio reached 108.21%. The year before the numbers were 2.13% and 82.77% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Eisai Co. Ltd. EBITDA is 504.40 M EUR, and current EBITDA margin is 11.11%. See more stats in Eisai Co. Ltd. financial statements.
Like other stocks, EII shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Eisai Co. Ltd. stock right from TradingView charts — choose your broker and connect to your account.